DOCSLIB.ORG

Stability-Indicating Reversed-Phase High-Performance Liquid Chromatography Method for Simultaneous Estimation of Methylcobalamin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stability-Indicating Reversed-Phase High-Performance Liquid Chromatography Method for Simultaneous Estimation of Methylcobalamin Online - 2455-3891 Vol 11, Issue 12, 2018 Print - 0974-2441 Research Article STABILITY-INDICATING REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF METHYLCOBALAMIN, ALPHA-LIPOIC ACID, PYRIDOXINE HCL, AND FOLIC ACID IN BULK AND COMBINED DOSAGE FORM PADMAJA V1*, PRASANTHI M1, MAYURI P2 1Department of Pharmaceutical Analysis, Nirmala College of Pharmacy, Atmakuru, Mangalagiri, Guntur, Andhra Pradesh, India, 2Departmen of Pharmaceutics, Nirmala College of Pharmacy, Atmakuru, Mangalagiri, Guntur, Andhra Pradesh, India. Email: [email protected] Received: 16 April 2018, Revised and Accepted: 02 August 2018 ABSTRACT Objectives: The purpose of the research is to develop a simple, precise, economical, accurate, reproducible, and sensitive method for the estimation of methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid drug product by reversed-phase high-performance liquid chromatography (RP-HPLC) method. Methods: New analytical method was developed for the estimation of methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid in drug product by RP-HPLC. The chromatographic separation was achieved on the Inertsil C18, 250 mm × 4.6 mm, 5 µm at ambient temperature. The separation achieved employing a mobile phase consists of buffer (added 5.05 g hexane-1-sulfonic acid is dissolved into 1000 mL of distilled water):acetonitrile in the ratio of 10:90% v/v. The flow rate was 1 mL/min and UV-visible spectrophotometer at 285 nm. The average retention time for methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid was found to be 3.5, 6.7, 8.5, and 9.3, respectively. Results: The developed method was validated as per ICH guidelines. All validation parameters were within the acceptable ranges. The assay methods were found to be linear from 0 to 2130 µg/mL for methylcobalamin, 0 to 142.5 μg/mL for alpha-lipoic acid, 0–4.54 µg/mL for pyridoxine hydrochloride, and 0–2 µg/mL for folic acid. The correlation coefficient was 0.999 for all drugs, respectively. The mean percentage values for the developed method Conclusion:were found to It be is concludedwithin the thatrange developed of 98–100.6%. method The was developed accurate, method precise, was linear, also reproducible, found to be robust. robust, and sensitive. Keywords: Alpha-lipoic acid, Folic acid, Methylcobalamin, Pyridoxine hydrochloride and Reversed-phase high-performance liquid chromatography, Validation. © 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i12.26715 INTRODUCTION for the estimation of methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid in bulk and combined dosage form by Methylcobalamin is a cobalamin, a form of Vitamin B . It differs from 12 reverse-phase high-performance liquid chromatography (Figs. 1-4). cyanocobalamin in that the cyano at the cobalt is replaced with a methyl MATERIALS AND METHODS ofgroup peripheral [1] and isneuropathy, chemically diabeticCoα-[α-(5,6-dimethylbenz-1H-imidazolyl)]- neuropathy, and as a preliminary Equipment treatmentCoβmethyl for cob amyotrophic amide. Methylcobalamin lateral sclerosis is [2].also The used alpha-lipoic in the treatment acid is The chromatographic technique was performed on a Waters, 2695 chemically (R)-5-(1,2-dithiolan-3-yl)pentatonic acid. Alpha-lipoic acid separation module, Empower, Version 2.0, reversed-phase C18 column is easily absorbed and transported across cell membranes; thus, free (Inertsil, 250 mm × 4.6 mm, 5 µm) as stationary phase, with Sartorius radical protection occurs both inside and outside of cells. Pyridoxine, also known as Vitamin B6, is a form of Vitamin B6 found commonly in membrane filter. food and used as dietary supplement [3]. Pyridoxine responsiveness analytical balance and vacuum microfiltration unit with 0.45 μ is associated with two particular missense mutations in the AGT gene Materials which lead to Gly170Arg and Phe152Ile amino acid replacements [4-6]. Pharmaceutically pure samples of methylcobalamin, alpha-lipoic acid, Folic acid, also known as Vitamin B9, is a form of synthetically produced pyridoxine hydrochloride, and folic acid were obtained from ICON water-soluble vitamin found in fortified food and supplements. Folate Laboratories, Vijayawada, India. is naturally derived from food, particularly from dark green leafy vegetables [7]. Folate and the biologically active folic acid, which is High-performance liquid chromatography grade methanol and converted to dihydrofolic acid in the liver, are essential in meeting acetonitrile were procured from on laboratories, Vijayawada, India. the requirements of the function of the human body. Folate is used to Selection of wavelength (for detection) literature review some methods are developed and validated by using In setting up the conditions for the development of assay method, the differentsynthesize, techniques repair, and likemethylate High deoxyribonucleicperformance liquid acid chromatography[8]. According to choice of detection wavelength was based on the scanned absorption [9,10], ultra performance liquid chromatography [11], ultravoilet- spectrum for methylcobalamin, alpha-lipoic acid, pyridoxine visible [12] technique with other combination of drugs. The proposed hydrochloride, and folic acid. The UV spectrum of methylcobalamin, method aimed to develop and validate a stability-indicating method alpha-lipoic acid, pyridoxine hydrochloride, and folic acid was obtained Padmaja et al. Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 302-307 Fig. 1: Chemical structure of methylcobalamin Fig. 2: Chemical structure of alpha-lipoic acid Fig. 5: UV spectrum of methylcobalamin, alpha-lipoic acid, pyridoxine HCL, and folic acid (285 nm) Chromatographic conditions The sample separation was achieved on a C18 (Inertsil, 250 mm × 4.6 mm, 5 µm) column, aided by mobile phase mixture of buffer: acetonitrile (10:90%v/v). The flow rate was 1 mL/min and Fig. 3: Chemical structure of pyridoxine hydrochloride at ambient temperature. ultraviolet detector at 285 nm, injection volume is 10 μL and maintained Preparation of mobile phase Buffer preparation: An accurate amount of 5.05 g hexane-1-sulfonic acid is dissolved into 1000-mL distilled water and adjusted to pH - 2.5 Mobilewith OPA. phase: Then Then, it was 10 filtered volumes through of buffer 0.45-μ and 90 membrane volumes offilter. acetonitrile were added and sonicated for 10 min. Preparation of standard stock solution Fig. 4: Chemical structure of folic acid Weighed accurately about 1500 mg methylcobalamin, 100 mg alpha- lipoic acid, 3 mg of pyridoxine, and 1.5 mg folic acid and transferred into 100-mL volumetric flask, added 70 mL of diluent, sonicated to 400 nm against blank as methanol. After thorough examination of the dissolve, and diluted up to volume with diluents to give a primarily spectra,separately the by wavelength scanning the 260 sample nm was over selected the wavelength for further range analysis. of 200– The stock solution containing 150 µg/mL of methylcobalamin, 10 µg/mL of overlay spectrum for methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid is shown in Fig. 5. of folic acid. alpha-lipoic acid, 0.3 μg/mL of pyridoxine hydrochloride, and 15 μg/mL 303 Padmaja et al. Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 302-307 Table 1: System suitability parameters for methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and folic acid Parameters Methylcobalamin Alpha-lipoic acid Pyridoxine hydrochloride Folic acid Acceptance criteria Retention time (min) 13.505 14.399 3.544 6.732 ±10 Theoretical plates 43409 19674 117890 3951 >2000 Tailing factor 1.22 1.89 1.61 1.81 <2 RSD 0.777 0.100 0.047 0.047 <2 RSD: Relative standard deviation Table 2: Method precision values for methylcobalamin Table 5: Method precision values for folic acid Rt (min) Area USP plate USP tailing Rt (min) Area USP plate USP tailing 13.505 5962 52654 1.21 6.732 158056 3954 1.81 13.512 5973 51764 1.27 6.738 158808 3944 1.84 13.505 5984 45180 1.57 6.732 157872 3957 1.80 13.512 5945 52104 1.27 6.738 157920 3957 1.84 13.505 5898 53121 1.21 6.732 158224 3951 1.81 13.512 5979 51792 1.26 6.738 158808 3944 1.84 Mean: 5957 Mean: 158281 %RSD: 0.534 %RSD: 0.269 Rt: Retention time, %RSD: Percentage relative standard deviation Rt: Retention time, %RSD: Percentage relative standard deviation Table 3: Method precision values for alpha-lipoic acid Table 6: LOD and LOQ values calculated from calibration curve Rt (min) Area USP plate USP tailing Parameters LOD=3.3 (SD/S) LOQ=10 (SD/S) 14.399 218860 19674 1.89 (µg/mL) (µg/mL) 14.409 218860 19470 1.88 Methylcobalamin 40.631 123.12 14.399 218652 19685 1.89 Alpha-lipoic acid 4.55 13.815 14.409 217920 19518 1.87 Pyridoxine Hcl 0.087 0.264 14.399 218845 19677 1.89 Folic acid 0.0447 0.135 14.409 218367 19496 1.89 LOD: Limit of detection, LOQ: Limit of quantitation, SD: Standard deviation, Mean: 218584 S: lope %RSD: 0.173 Rt: Retention time, %RSD: Percentage relative standard deviation Accuracy The accuracy of the method was determined by calculating the recoveries of Table 4: Method precision values for pyridoxine hydrochloride methylcobalamin, alpha-lipoic acid, pyridoxine hydrochloride, and Rt (min) Area USP plate USP tailing and 150% of the working strength of methylcobalamin, 3.544 117890 6272 1.33 alpha-lipoicfolic acid by analyzingacid, pyridoxine solutions hydrochloride, containing approximately and folic acid. 50%, 100%, 3.547 117967 6014 1.33 3.544 117478 6274 1.42 Robustness 3.547 117785 6018 1.36 Robustness is the measure of method remains unaffected by small 3.544 117769 6275 1.33 3.547 117967 6014 1.33 deliberate changes in method parameters such as flow rate and detection Mean: 117809 of wavelength on assay of the analyte of interest.
Load more

Recommended publications
  • Methionine Synthase Supports Tumor Tetrahydrofolate Pools
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Methionine synthase supports tumor tetrahydrofolate pools Joshua Z. Wang1,2,#, Jonathan M. Ghergurovich1,3,#, Lifeng Yang1,2, and Joshua D. Rabinowitz1,2,* 1 Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA 2 Department of Chemistry, Princeton University, Princeton, New Jersey, USA 3 Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA # These authors contributed equally to this work. *Corresponding author: Joshua Rabinowitz Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, Princeton University, Washington Rd, Princeton, NJ 08544, USA Phone: (609) 258-8985; e-mail: [email protected] Conflict of Interest Disclosure: J.D.R. is a paid advisor and stockholder in Kadmon Pharmaceuticals, L.E.A.F. Pharmaceuticals, and Rafael Pharmaceuticals; a paid consultant of Pfizer; a founder, director, and stockholder of Farber Partners and Serien Therapeutics. JDR and JMG are inventors of patents in the area of folate metabolism held by Princeton University. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Mammalian cells require activated folates to generate nucleotides for growth and division. The most abundant circulating folate species is 5-methyl tetrahydrofolate (5-methyl- THF), which is used to synthesize methionine from homocysteine via the cobalamin-dependent enzyme methionine synthase (MTR).
    [Show full text]
  • The Vitamin B12 Coenzyme
    THE VITAMIN B12 COENZYME D. DoLPHIN, A. W. JoHNSON, R. RoDRIGO and N. SHAW Department of Chemistry, University of Nottingham, U.K. INTRODUCTION In 19•58 Barker and his associatesl-3 recognized a new coenzyme which controlled the conversion of glutamate into ß-methylaspartate by Clostridium tetanomorpkim. The coenzyme was shown4 to be related to !f;-vitamin B12, i.e. contair ing an adenine nucleotide grouping in place of the 5,6-dimethyl­ benziminawle nucleotide of vitamin B12, although similar coenzymes con­ taining btnziminazole or 5,6-dimethylbenziminazole were produced by growing C. tetanomorphum in the presence of the a ppropriate base5. Other variations of the nucleotide base have been achieved using Propionibacterium arabinosum in the presence of other purines and benziminazoles6• The pres­ ence of;:he coenzymes in a wide variety of micro-organisms such as several species of Actinomycetes including Streptomyces olivaceus and S. griseus has been dem( mstrated by the glutamate isomerase assay7 or by isolation. I t appears thü Vitamin B12 and its analogues are always biosynthesized in the form of their coenzymes. Preliminary physical and chemical studies sug­ gested that in the 5,6-dimethylbenzirninazolyl cobamide coenzyme the cyanide gr )up of vitamin B12, cyanocobalamin, was replaced by an adenine nucleoside':, 5, 8 and the determination9 of the complete structure (I; R = 5'-de·)xyadenosyl) of the coenzyme by X-ray analysis revealed the existence c f an essentially covalent bond between the cobalt atom and the S'.. carbon üom of the additional 5'-deoxyadenosine group. The molecule Me CH 2• CO· NH2 In the vitamin 8 12 coenzyme R =5' - deoxyadenosyl = Me Me 539 D.
    [Show full text]
  • L-Carnitine, Mecobalamin and Folic Acid Tablets) TRINERVE-LC
    For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only (L-Carnitine, Mecobalamin and Folic acid Tablets) TRINERVE-LC 1. Name of the medicinal product Trinerve-LC Tablets 2. Qualitative and quantitative composition Each film- coated tablets contains L-Carnitine…………………….500 mg Mecobalamin……………….1500 mcg Folic acid IP…………………..1.5mg 3. Pharmaceutical form Film- coated tablets 4. Clinical particulars 4.1 Therapeutic indications Vitamin and micronutrient supplementation in the management of chronic disease. 4.2 Posology and method of administration For oral administration only. One tablet daily or as directed by physician. 4.3 Contraindications Hypersensitivity to any constituent of the product. 4.4 Special warnings and precautions for use L-Carnitine The safety and efficacy of oral L-Carnitine has not been evaluated in patients with renal insufficiency. Chronic administration of high doses of oral L-Carnitine in patients with severely compromised renal function or in ESRD patients on dialysis may result in accumulation of the potentially toxic metabolites, trimethylamine (TMA) and trimethylamine-N-oxide (TMAO), since these metabolites are normally excreted in the urine. Mecobalamin Should be given with caution in patients suffering from folate deficiency. The following warnings and precautions suggested with parent form – vitamin B12 The treatment of vitamin B12 deficiency can unmask the symptoms of polycythemia vera. Megaloblastic anemia is sometimes corrected by treatment with vitamin B12. But this can have very serious side effects. Don’t attempt vitamin B12 therapy without close supervision by healthcare provider. Do not take vitamin B12 if Leber’s disease, a hereditary eye disease.
    [Show full text]
  • The Potential Protective Role of Vitamin K in Diabetic Neuropathy
    VITAMINS The potential protective role of vitamin K in diabetic neuropathy DILIP MEHTA Viridis Biopharma 6/10 Jogani Industrial Complex ew cases of diabetes are symptomatic pain relief (3-5). V. N. Purav Marg, Chunabhatti increasing worldwide at a rapid Mumbai 400022, India The etiopathology of peripheral pace, with the total number of neuropathy is poorly understood and many [email protected] people with diabetes was projected factors, including dietary deficiencies, may www.viridisbiopharma.com Nto rise from 171 million in 2000 to 366 million contribute to the clinical manifestation of the in 2030 – an increase of nearly 200 million in condition. Deficiency of vitamin B12 (also only three decades. There are more cases of known as cobalamin), which results in a lack diabetes in women and urban populations, of a related compound, methylcobalamin, is with diabetes in developing countries projected manifested by megaloblastic anemia, and to double in the coming years (1). has been associated with significant Based on reports from the Centers for neurological pathology, especially peripheral Disease Control and Prevention, type 2 neuropathy (6-8). Vitamin B12 is also diabetes dult onset diabetes affects associated with the onset of diabetic approximately 9.3% of the general neuropathy. In patients with diabetic population in the United States in contrast to neuropathy, vitamin B12 deficiency may be 25.9% among those 65 years or older (2). aggravated by the use of antidiabetic agents Diabetes mellitus accounts for 90% of the such as metformin (9-11). Even short-term cases of diabetes patients (3,4). treatment with metformin causes a decrease The prevalence of type 2 diabetes in serum cobalamin, folic acid and an increases with age, higher then 25 body increase in homocysteine, which leads to mass index and the presence of the disease peripheral neuropathy in patients with in family history.
    [Show full text]
  • Potential Benefits of Methylcobalamin: a Review
    Open Access Austin Journal of Pharmacology and Therapeutics Review Article Potential Benefits of Methylcobalamin: A Review Gupta JK* and Qureshi Shaiba Sana Department of Pharmacology, GLA University Mathura, Abstract India Methylcobalamin is an active form of vitamin B12 that helps in synthesis *Corresponding author: Jeetendra Kumar Gupta, of methionine and S-adenosylmethionine. It is required for integrity of myelin, Department of Pharmacology, Institute of Pharmaceutical neuronal function, proper red blood cell formation and DNA synthesis. The largest Research, GLA University Mathura, India group of vitamin B12 deficiency is found in typical vegetarians all over the world, which can be alleviated with its analogue Methylcobalamin. It is a beneficial Received: August 17, 2015; Accepted: September 30, drug to most of the common disorders like cardiovascular disorders, diabetes, 2015; Published: October 08, 2015 anemia, hyperhomocysteinemia and degenerative disorders. Methylcobalamin helps in the synthesis of neuronal lipids, regeneration of axonal nerves and has neuroprotective activity, which promote neurons to function in proper way and thus improves Alzheimer disease, Parkinsonism, Dementia and neuropathic syndromes. It is an approved treatment for peripheral neuropathy. Keywords: Mecobalamin; Neuropathy; Anemia; Nootropic; Dietary supplement Abbreviations essential for cell growth and replication. Sometimes the liver cannot convert cyanocobalamin into adequate amount of methylcobalamin SAMe: S-Adenosyl Methionine; ERK: Extracellular Signal- needed for proper neuronal functioning. Through enhanced Regulated Kinases; PKB: Protein Kinase B; B-globulin: Beta Globulin; methylation, it exerts its nerve cell protective effect and accelerates ENFD: Epidermal Nerve Fiber Density; DPN: Diabetic Peripheral its growth. A lot of energy is required for cyanocobalamin to remove Neuropathy; NSAIDs: Non Steroidal Anti Inflammatory Drugs; THF: its cyanide and replaces it with methyl group [3].
    [Show full text]
  • Vitamin and Mineral Requirements in Human Nutrition
    P000i-00xx 3/12/05 8:54 PM Page i Vitamin and mineral requirements in human nutrition Second edition VITPR 3/12/05 16:50 Page ii WHO Library Cataloguing-in-Publication Data Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements (1998 : Bangkok, Thailand). Vitamin and mineral requirements in human nutrition : report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. 1.Vitamins — standards 2.Micronutrients — standards 3.Trace elements — standards 4.Deficiency diseases — diet therapy 5.Nutritional requirements I.Title. ISBN 92 4 154612 3 (LC/NLM Classification: QU 145) © World Health Organization and Food and Agriculture Organization of the United Nations 2004 All rights reserved. Publications of the World Health Organization can be obtained from Market- ing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permis- sion to reproduce or translate WHO publications — whether for sale or for noncommercial distri- bution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; e-mail: [email protected]), or to Chief, Publishing and Multimedia Service, Information Division, Food and Agriculture Organization of the United Nations, 00100 Rome, Italy. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • The Efficacy and Safety of Intramuscular Injections Of
    Original Article Singapore Med J 2011; 52(12) : 868 The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial Chiu C K, Low T H, Tey Y S, Singh V A, Shong H K ABSTRACT both singly or in combination with other forms Introduction:Chronic, nonspecific low back of treatment. pain is a difficult ailment to treat and poses an economic burden in terms of medical Keywords: methylcobalamin, nonspecific low expenses and productivity loss. The aim of back pain, vitamin B12 this study was to determine the efficacy and Singapore Med J 2011; 52(12): 868-873 safety of intramuscular metylcobalamin in the treatment of chronic nonspecific low back INTRODUCTION pain. Low back pain (LBP) affects a substantial proportion of the population. Almost every person will encounter an Methods: This was a double-blinded, episode of back pain at some point in one’s life. Back randomised, controlled experimental study. pain does not discriminate based on gender, age, race or 60 patients were assigned to either the culture. It disables the working adult from performing his methylcobalamin group or the placebo group. duties and paralyses the society due to the cost incurred The former received intramuscular injections in terms of treatment and productivity loss. In 1988, a of 500 mcg parenteral methylcobalamin in 1 survey was conducted in a semirural area in Malaysia. Department of ml solution three times a week for two weeks, Orthopaedic A total of 2,594 individuals from a multi-racial (Malay, Surgery, and the placebo group received 1 ml normal Chinese, Indian) community were interviewed.
    [Show full text]
  • Cyanocobalamin-A Case for Withdrawal
    686 Journal of the Royal Society of Medicine Volume 85 November 1992 Cyanocobalamin- a case for withdrawal: discussion paper A G Freeman MD FRCP Meadow Rise, 3 Lakeside, Swindon SN3 IQE Keywords: anaemia, pernicious; optic neuropathies; chronic cyanide intoxication; hydroxocobalamin; cyanocobalamin It seems evident that controversy still surrounds the reduced ability to detoxify the cyanide in the tobacco- treatment of pernicious anaemia and other vitamin smoke to which they are exposed'0. B12 deficiency disorders. The long quest for the 'anti- Patients with tobacco amblyopia who have normal pernicious anaemia factor' in the liver seemed to serum vitamin B12 levels need not continue therapy have ended in 1948 when pure cyanocobalamin was with intramuscular hydroxocobalamin once their isolated. This was found to be very active thera- visual acuity and visual fields have returned to peutically when given by intramuscular injection and normal providing they abstain from further smoking. was non-toxic in extremely high doses'. However, those patients who have low serum vitamin Lederle, in a recent commentary2, advocates that B12 levels or evidence of -defective vitamin B12 patients with pernicious anaemia should now be absorption will need to continue-indefinitely with treated with oral cyanocobalamin. He is not without hydroxocobalamin irrespective of their smoking support in that 40% of patients with pernicious habits as will all patients with pernicious anaemia anaemia in Sweden are being similarly treated3. and other vitamin B12 deficiency disorders who are He further states that such!- treatment is cheap at risk of developing- optic neuropathy if they and effective, produces clinical and haematological are smokers.
    [Show full text]
  • Structural Basis for the Inhibition of Human 5,10-Methenyltetrahydrofolate Synthetase by N10-Substituted Folate Analogues
    Published OnlineFirst September 8, 2009; DOI: 10.1158/0008-5472.CAN-09-1927 Experimental Therapeutics, Molecular Targets, and Chemical Biology Structural Basis for the Inhibition of Human 5,10-Methenyltetrahydrofolate Synthetase by N10-Substituted Folate Analogues Dong Wu,1 Yang Li,1 Gaojie Song,1 Chongyun Cheng,1 Rongguang Zhang,2 Andrzej Joachimiak,2 NeilShaw, 1 and Zhi-Jie Liu1 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China and 2Structural Biology Center, Argonne National Laboratory, Argonne, Illinois Abstract of the one-carbon metabolic network, dihydrofolate reductase, 5,10-Methenyltetrahydrofolate synthetase (MTHFS) regulates which catalyzes the conversion of dihydrofolate to tetrahydrofolate. the flow of carbon through the one-carbon metabolic network, Similarly, colorectal and pancreatic cancers are routinely treated by which supplies essential components for the growth and administration of the pyrimidine analogue 5-fluorouracil (5-FU), proliferation of cells. Inhibition of MTHFS in human MCF-7 which inhibits thymidylate synthase (TS; ref. 6). TS converts breast cancer cells has been shown to arrest the growth of deoxyuridylate to deoxythymidylate using a carbon donated by cells. Absence of the three-dimensional structure of human 5,10-methylenetetrahydrofolate (Fig. 1). This conversion is essential MTHFS (hMTHFS) has hampered the rational design and for DNA synthesis (7). To increase the clinical efficiency of the optimization of drug candidates. Here, we report the treatment, 5-formyltetrahydrofolate is often coadministered along structures of native hMTHFS, a binary complex of hMTHFS with 5-FU. The beneficial effect of administering 5-formyltetrahy- with ADP, hMTHFS bound with the N5-iminium phosphate drofolate during the therapy with 5-FU is a consequence of the reaction intermediate, and an enzyme-product complex of 5,10-methenyltetrahydrofolate synthetase (MTHFS)–catalyzed hMTHFS.
    [Show full text]
  • Considerations for Crop Biofortification
    fpls-09-00443 April 4, 2018 Time: 16:15 # 1 REVIEW published: 06 April 2018 doi: 10.3389/fpls.2018.00443 Toward Eradication of B-Vitamin Deficiencies: Considerations for Crop Biofortification Simon Strobbe and Dominique Van Der Straeten* Laboratory of Functional Plant Biology, Department of Biology, Ghent University, Ghent, Belgium ‘Hidden hunger’ involves insufficient intake of micronutrients and is estimated to affect over two billion people on a global scale. Malnutrition of vitamins and minerals is known to cause an alarming number of casualties, even in the developed world. Many staple crops, although serving as the main dietary component for large population groups, deliver inadequate amounts of micronutrients. Biofortification, the augmentation of natural micronutrient levels in crop products through breeding or genetic engineering, is a pivotal tool in the fight against micronutrient malnutrition (MNM). Although these approaches have shown to be successful in several species, a more extensive knowledge of plant metabolism and function of these micronutrients is required to refine and improve biofortification strategies. This review focuses on the relevant B-vitamins Edited by: (B1, B6, and B9). First, the role of these vitamins in plant physiology is elaborated, Alexander Arthur Theodore Johnson, as well their biosynthesis. Second, the rationale behind vitamin biofortification is University of Melbourne, Australia illustrated in view of pathophysiology and epidemiology of the deficiency. Furthermore, Reviewed by: advances in biofortification, via metabolic engineering or breeding, are presented. Finally, Francesco Di Gioia, University of Florida, United States considerations on B-vitamin multi-biofortified crops are raised, comprising the possible Aymeric Goyer, interplay of these vitamins in planta.
    [Show full text]
  • Methylcobalamin/ B12 Liquid
    Product Information Sheet – January 2016 Methylcobalamin/ B12 liquid Introduced 2002 What Is It? Are There Any Potential Drug Interactions? Methylcobalamin is an activated, highly bioavailable form of vitamin At this time, there are no known adverse reactions when taken in B12, which acts as the principal circulating form of cobalamin in the conjunction with medications. body. It is available in liquid and capsule form.* Methylcobalamin Uses For Methylcobalamin Nervous System Health: In recent studies, methylcobalamin has each vegetarian capsule contains v 3 demonstrated an enhanced ability to support neurological function. vitamin B12 (as methylcobalamin) .................................................. 1,000 mcg other ingredients: hypoallergenic plant fiber (cellulose), vegetarian This form of vitamin B12 promotes protein synthesis for maintaining capsule (cellulose, water) healthy nerve cells and myelin. Methylcobalamin may also help to moderate levels of glutamate in the brain, encouraging healthy 1–3 capsules daily, in divided doses, with meals. brain cell activity, as well as memory, mood, and cognitive function. B liquid In general, vitamin B12 works with folate to promote DNA and red 12 blood cell health. Additionally, vitamin B12 is an important cofactor for energy metabolism and a vital component of the methionine one ml (0.03 fl oz) (one full dropper) contains v synthase pathway, which supports healthy homocysteine vitamin B12 ...................................................................................................1,000 mcg metabolism and S-adenosylmethionine (SAMe) production.* stevia .....................................................................................................................0.5 mg other ingredients: purified water, natural glycerin, citric acid, potassium What Is The Source? sorbate serving size: 1 ml (0.03 fl oz) (one full dropper) Pure Encapsulations methylcobalamin is produced from corn dextrose servings per container: 30 fermentation.
    [Show full text]
  • Route and Type of Formulation Administered Influences The
    Journal of Functional Biomaterials Article Route and Type of Formulation Administered Influences the Absorption and Disposition of Vitamin B12 Levels in Serum Luis Vitetta 1,2,* ID , Joyce Zhou 2, Rachel Manuel 2, Serena Dal Forno 2, Sean Hall 2 ID and David Rutolo 2 1 Sydney Medical School, The University of Sydney, Sydney 2006, Australia 2 Medlab Clinical, Sydney 2015, Australia; [email protected] (J.Z.); [email protected] (R.M.); [email protected] (S.D.F.); [email protected] (S.H.); [email protected] (D.R.) * Correspondence: [email protected] or [email protected] Received: 23 December 2017; Accepted: 18 January 2018; Published: 21 January 2018 Abstract: The administration of biological compounds that optimize health benefits is an ever-evolving therapeutic goal. Pharmaceutical and other adjunctive biological compounds have been administered via many different routes in order to produce a systemic pharmacological effect. The article summarizes the findings from an Australian comparative study in adults administered vitamin B12 through different oral delivery platforms. A total of 16 subjects (9 males, 7 females) voluntarily partook in a comparative clinical study of five different vitamin B12 formulations across a six-month period, completing 474 person-hours of cumulative contribution, that was equivalent to an n = 60 participation. A nanoparticle delivered vitamin B12 through a NanoCelle platform was observed to be significantly (p < 0.05) better absorbed than all other dose equivalent platforms (i.e., tablets, emulsions, or liposomes) from baseline to 1, 3, and 6 h of the study period. The nanoparticle platform delivered vitamin B12 demonstrated an enhanced and significant absorption profile as exemplified by rapid systemic detection (i.e., 1 h from baseline) when administered to the oro-buccal mucosa with no reports of any adverse events of toxicity.
    [Show full text]